Figure 1.
Selection of medical files potentially related to cannabis use (step 1, see § Methods). Bold figures correspond to the numbers of hospitalizations; the corresponding numbers of patients are in brackets. *For instance, we identified 701 hospitalizations related to the use of cannabinoids, which corresponded to a sample of 532 patients. ICD-10: WHO International classification of diseases, 10th revision. PMSI: Programme de médicalisation des systèmes d'information. F19: This category should be used when two or more psychoactive substances are known to be involved, but it is impossible to assess which substance is contributing most to the disorders. It should also be used when the exact identity of some or even all the psychoactive substances being used is uncertain or unknown, since many multiple drug users themselves often do not know the details of what they are taking